8-K filing — STANDARD BIOTOOLS INC. (LAB)
Filed: 2026-10-05 AccNo: 0001140361-26-038624 Size: 188 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Standard BioTools Terminates Its Previously Announced Agreement To Sell Its Mass Cytometry Business To Multiplex Bio; Co. Enters Into A Definitive Agreement To Sell Its Mass Cytometry Business To Element Biosystems For $5.5M In Cash Payable
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Standard BioTools Sells Microfluidics Business To ARCHIMED; Amount Not Disclosed
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—IRDM, VRME, VAL and LAB
Monteverde & Associates PC is investigating four merger transactions to determine if shareholders are receiving fair value. The investigations cover Iridium Communications' sale to Rocket Lab, VerifyMe's merger with Open World Ltd, Valaris' sale to Transocean Ltd, and Standard Biotools' merger with Treeline Biosciences. The firm is offering free consultations to shareholders with concerns about these deals.